Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
A phase 2 trial of PF-08634404 in non-small-cell lung cancer and small-cell lung cancer, run by Pfizer, now recruiting.
Overview
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC is a phase 2 interventional study registered as NCT07489066 by Pfizer, with 120 participants planned, started 2026-06-30 and due to reach its primary completion in 2028-07-29. Interventions recorded: PF-08634404, Chemotherapy Regimen 1, Chemotherapy Regimen 2. Conditions listed: Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC), Lung Neoplasms. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialSymbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed
Shares PF-08634404, Pfizer (incl. Seagen), Small-cell lung cancer.
- TrialSymbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Shares PF-08634404, Pfizer (incl. Seagen), Non-small-cell lung cancer.
- TrialSymbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Shares PF-08634404, Pfizer (incl. Seagen), Non-small-cell lung cancer.
- TrialSymbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Shares PF-08634404, Pfizer (incl. Seagen), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialSSGJ-707 in Advanced Non-Small Cell Lung Cancer
Shares PF-08634404, Non-small-cell lung cancer.
- TrialSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Shares PF-08634404, Pfizer (incl. Seagen).
- TrialThis is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lu
Shares Pfizer (incl. Seagen), Small-cell lung cancer, Non-small-cell lung cancer.
- TrialSymbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Shares PF-08634404, Pfizer (incl. Seagen).